Clinical and laboratory features of viral hepatitis A in children
Jazyk angličtina Země Rakousko Médium print-electronic
Typ dokumentu časopisecké články
- MeSH
- bolesti břicha epidemiologie MeSH
- dítě MeSH
- hepatitida A krev diagnóza epidemiologie MeSH
- hodnocení rizik MeSH
- horečka epidemiologie MeSH
- kojenec MeSH
- komorbidita MeSH
- lidé MeSH
- mladiství MeSH
- novorozenec MeSH
- předškolní dítě MeSH
- prevalence MeSH
- žloutenka epidemiologie MeSH
- zvracení epidemiologie MeSH
- Check Tag
- dítě MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- novorozenec MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika epidemiologie MeSH
Recent outbreaks of viral hepatitis A in non-endemic European countries and the potential outbreak risk in susceptible populations has led us to evaluate the clinical characteristics of children hospitalised with hepatitis A. Retrospective study included 118 children (68 boys and 50 girls) with the mean age of 8.5 years hospitalised at Hospital Na Bulovce in Prague from June 2008 to June 2009. The clinical course was symptomatic icteric in 57 (48.3 %) children, symptomatic anicteric in 23 (19.5 %), subclinical in 22 (18.6 %) and asymptomatic inapparent in 16 (13.6 %). The relapse of the disease occurred in three patients. There were no cases of fulminant hepatitis. The most frequent symptoms included jaundice (57 cases), abdominal pain/discomfort (38), vomiting (38), dark urine (37), subfebrility (29) and fever (25). Hepatic injury markers were substantially elevated in icteric patients, but moderate elevations were identified in anicteric and subclinical cases as well. Lower white blood cell and lymphocyte counts were independently associated with symptomatic and more severe clinical course. Active immunisation was provided to 22 patients, and as a post-exposure prophylaxis to 19 of them. The clinical course and laboratory parameters in vaccinated children were not significantly different from non-vaccinated children. The clinical course of hepatitis A was largely self-limiting and benign. Asymptomatic infections are frequent, representing risk for disease spread; however, they are associated with elevations of hepatic injury markers. The inclusion of significant proportion of asymptomatic cases that were identified and investigated only because of active epidemiological surveillance in the outbreak focus represents the particular asset of this study.
Zobrazit více v PubMed
Vaccine. 2010 Jan 8;28(3):583-8 PubMed
Baillieres Clin Gastroenterol. 1990 Sep;4(3):695-705 PubMed
Pediatrics. 2000 Oct;106(4):E54 PubMed
J Infect Dis. 1998 Dec;178(6):1579-84 PubMed
Clin Immunol Immunopathol. 1974 Apr;2(3):353-60 PubMed
Clin Microbiol Rev. 2001 Jan;14(1):38-58 PubMed
J Clin Virol. 2005 Jan;32(1):24-8 PubMed
Vaccine. 2003 Jun 2;21(19-20):2246-9 PubMed
Vaccine. 2000 Feb 18;18 Suppl 1:S71-4 PubMed
Am J Public Health. 1997 Oct;87(10):1715-7 PubMed
Expert Rev Vaccines. 2008 Jul;7(5):535-45 PubMed
Clin Chim Acta. 1972 May;38(2):419-34 PubMed
Am J Med Sci. 1947 Apr;213(4):395-409 PubMed
Epidemiol Rev. 2006;28:101-11 PubMed
Eur J Epidemiol. 2006;21(12):893-9 PubMed
Lancet. 1998 May 30;351(9116):1643-9 PubMed
Medicina (B Aires). 1985;45(3):273-8 PubMed
Intervirology. 2010;53(1):15-9 PubMed
Euro Surveill. 2009 Jan 22;14(3): PubMed
J Viral Hepat. 2008 Oct;15 Suppl 2:26-32 PubMed
Vaccine. 1992;10 Suppl 1:S18-20 PubMed
Hepatology. 2006 Dec;44(6):1589-97 PubMed
Cas Lek Cesk. 1981 Feb 12;120(6):152-4 PubMed
Lancet. 1992 May 16;339(8803):1198-9 PubMed
Epidemiol Infect. 2004 Dec;132(6):1005-22 PubMed
Euro Surveill. 2009 Jan 22;14(3): PubMed
Southeast Asian J Trop Med Public Health. 1995 Mar;26(1):104-8 PubMed
